Literature DB >> 21576279

Heterogeneity of intramural function in hypertrophic cardiomyopathy: mechanistic insights from MRI late gadolinium enhancement and high-resolution displacement encoding with stimulated echoes strain maps.

Anthony H Aletras1, Gauri S Tilak, Li-Yueh Hsu, Andrew E Arai.   

Abstract

BACKGROUND: In hypertrophic cardiomyopathy (HCM), myocardial abnormalities are commonly heterogeneous. Two patterns of late gadolinium enhancement (LGE) have been reported: a bright "confluent" and an intermediate intensity abnormality termed "diffuse," each representing different degrees of myocardial scarring. We used MRI to study the relation between intramural cardiac function and the extent of fibrosis in HCM. The aim of this study was to determine whether excess collagen or myocardial scarring, as determined by LGE MRI, are the primary mechanisms leading to heterogeneous regional contractile function in patients with HCM. METHODS AND
RESULTS: Intramural left ventricular strain, transmural left ventricular function, and regions of myocardial fibrosis/scarring were imaged in 22 patients with HCM, using displacement encoding with stimulated echoes (DENSE), cine MRI, and LGE. DENSE systolic strain maps were qualitatively and quantitatively compared with LGE images. Intramural systolic strain by DENSE was significantly depressed within areas of confluent and diffuse LGE but also in the core of the most hypertrophic nonenhanced segment (all P < 0.001 versus nonhypertrophied segments). DENSE demonstrated an unexpected inner rim of largely preserved contractile function and a noncontracting outer wall within hypertrophic segments in 91% of patients.
CONCLUSIONS: LGE predicted some but not all of the heterogeneity of intramural contractile abnormalities. This indicates that myocardial scarring or excess interstitial collagen deposition does not fully explain the observed contractile heterogeneity in HCM. Thus, myofibril disarray or other nonfibrotic processes affect systolic function in a large number of patients with HCM.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21576279      PMCID: PMC3460377          DOI: 10.1161/CIRCIMAGING.110.958751

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  48 in total

1.  DENSE: displacement encoding with stimulated echoes in cardiac functional MRI.

Authors:  A H Aletras; S Ding; R S Balaban; H Wen
Journal:  J Magn Reson       Date:  1999-03       Impact factor: 2.229

Review 2.  MRI of hypertrophic cardiomyopathy: part I, MRI appearances.

Authors:  Mark W Hansen; Naeem Merchant
Journal:  AJR Am J Roentgenol       Date:  2007-12       Impact factor: 3.959

3.  Myocardial fibrosis and regional function in hypertrophic cardiomyopathy: may the force be with you.

Authors:  Shemy Carasso; Harry Rakowski
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

4.  Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: the significance of type III and VI collagens.

Authors:  M Kitamura; M Shimizu; H Ino; K Okeie; M Yamaguchi; N Funjno; H Mabuchi; I Nakanishi
Journal:  Clin Cardiol       Date:  2001-04       Impact factor: 2.882

5.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

Review 6.  Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.

Authors:  Houman Ashrafian; Charles Redwood; Edward Blair; Hugh Watkins
Journal:  Trends Genet       Date:  2003-05       Impact factor: 11.639

7.  Measurement of myocardial mechanics in mice before and after infarction using multislice displacement-encoded MRI with 3D motion encoding.

Authors:  Wesley D Gilson; Zequan Yang; Brent A French; Frederick H Epstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-10-28       Impact factor: 4.733

8.  Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging.

Authors:  Zoran B Popović; Deborah H Kwon; Micky Mishra; Adisai Buakhamsri; Neil L Greenberg; Maran Thamilarasan; Scott D Flamm; James D Thomas; Harry M Lever; Milind Y Desai
Journal:  J Am Soc Echocardiogr       Date:  2008-12       Impact factor: 5.251

9.  Abnormalities in T2-weighted cardiovascular magnetic resonance images of hypertrophic cardiomyopathy: regional distribution and relation to late gadolinium enhancement and severity of hypertrophy.

Authors:  Hassan Abdel-Aty; Myra Cocker; Oliver Strohm; Neil Filipchuk; Matthias G Friedrich
Journal:  J Magn Reson Imaging       Date:  2008-07       Impact factor: 4.813

10.  Complementary displacement-encoded MRI for contrast-enhanced infarct detection and quantification of myocardial function in mice.

Authors:  Wesley D Gilson; Zequan Yang; Brent A French; Frederick H Epstein
Journal:  Magn Reson Med       Date:  2004-04       Impact factor: 4.668

View more
  12 in total

1.  3.0 T magnetic resonance myocardial perfusion imaging for semi-quantitative evaluation of coronary microvascular dysfunction in hypertrophic cardiomyopathy.

Authors:  Liang Yin; Hai-Yan Xu; Sui-Sheng Zheng; Ying Zhu; Jiang-Xi Xiao; Wei Zhou; Si-Si Yu; Liang-Geng Gong
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-13       Impact factor: 2.357

2.  Microstructurally Anchored Cardiac Kinematics by Combining In Vivo DENSE MRI and cDTI.

Authors:  Luigi E Perotti; Patrick Magrath; Ilya A Verzhbinsky; Eric Aliotta; Kévin Moulin; Daniel B Ennis
Journal:  Funct Imaging Model Heart       Date:  2017-05-23

3.  N-terminal pro-brain natriuretic peptide levels and aortic diameters.

Authors:  Liat S Gutin; Vladimir K Bakalov; Douglas R Rosing; Andrew E Arai; Ahmed M Gharib; Carolyn A Bondy
Journal:  Am Heart J       Date:  2012-09       Impact factor: 4.749

4.  In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy.

Authors:  Pedro F Ferreira; Philip J Kilner; Laura-Ann McGill; Sonia Nielles-Vallespin; Andrew D Scott; Siew Y Ho; Karen P McCarthy; Margarita M Haba; Tevfik F Ismail; Peter D Gatehouse; Ranil de Silva; Alexander R Lyon; Sanjay K Prasad; David N Firmin; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2014-11-12       Impact factor: 5.364

Review 5.  Strain imaging using cardiac magnetic resonance.

Authors:  A Scatteia; A Baritussio; C Bucciarelli-Ducci
Journal:  Heart Fail Rev       Date:  2017-07       Impact factor: 4.214

Review 6.  Clinical applications of feature-tracking cardiac magnetic resonance imaging.

Authors:  Daniele Muser; Simon A Castro; Pasquale Santangeli; Gaetano Nucifora
Journal:  World J Cardiol       Date:  2018-11-26

7.  Estimating cardiomyofiber strain in vivo by solving a computational model.

Authors:  Luigi E Perotti; Ilya A Verzhbinsky; Kévin Moulin; Tyler E Cork; Michael Loecher; Daniel Balzani; Daniel B Ennis
Journal:  Med Image Anal       Date:  2020-12-05       Impact factor: 8.545

8.  Mechanical aberrations in hypetrophic cardiomyopathy: emerging concepts.

Authors:  Dimitrios Ntelios; Georgios Tzimagiorgis; Georgios K Efthimiadis; Haralambos Karvounis
Journal:  Front Physiol       Date:  2015-08-19       Impact factor: 4.566

9.  Reproducibility of cine displacement encoding with stimulated echoes (DENSE) cardiovascular magnetic resonance for measuring left ventricular strains, torsion, and synchrony in mice.

Authors:  Christopher M Haggerty; Sage P Kramer; Cassi M Binkley; David K Powell; Andrea C Mattingly; Richard Charnigo; Frederick H Epstein; Brandon K Fornwalt
Journal:  J Cardiovasc Magn Reson       Date:  2013-08-27       Impact factor: 5.364

10.  Fast 3-Breath-Hold 3-Dimensional Tagging Cardiac Magnetic Resonance in Patients with Hypertrophic Myocardial Diseases: A Feasibility Study.

Authors:  Yasuo Amano; Fumi Yamada; Hidenobu Hashimoto; Makoto Obara; Kuniya Asai; Shinichiro Kumita
Journal:  Biomed Res Int       Date:  2016-02-28       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.